HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Summer Sale Get Elite for just $199.50 Claim Now
Market News Market Pulse Stocks News ETF News Crypto News

OPKO Health, Inc.

Contributing Author

Recent Articles by OPKO Health, Inc.

Jun-15
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026 OPK GlobeNewswire
May-12
OPKO Health's ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies OPK GlobeNewswire
Apr-30
OPKO Health Expands Nicoya Agreement to Support RAYALDEE Commercialization in Greater China OPK GlobeNewswire
Apr-30
BioReference Launches BioReference Direct, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform OPK GlobeNewswire
Apr-28
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results OPK -8.26% OPK GlobeNewswire
Apr-22
OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas OPK GlobeNewswire
Apr-21
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 OPK GlobeNewswire
Apr-08
OPKO Health's ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19 OPK GlobeNewswire
Feb-27
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit OPK GlobeNewswire
Feb-26
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results OPK GlobeNewswire
Feb-12
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 OPK GlobeNewswire
Feb-04
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism OPK GlobeNewswire
Jan-06
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference OPK GlobeNewswire
Nov-19
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference OPK GlobeNewswire
Oct-29
OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results OPK GlobeNewswire
Oct-29
OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications OPK GlobeNewswire
Oct-28
OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers OPK GlobeNewswire
Oct-22
OPKO Health to Report Third Quarter 2025 Financial Results on October 29 OPK GlobeNewswire
Jul-31
OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results OPK -7.03% OPK GlobeNewswire
Jul-24
OPKO Health to Report Second Quarter 2025 Financial Results on July 31 OPK GlobeNewswire
Jul-08
OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress OPK GlobeNewswire
Jun-25
OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium OPK GlobeNewswire
Jun-25
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting OPK GlobeNewswire
Jun-09
OPKO Health's ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development OPK GlobeNewswire
May-15
OPKO Health to Participate in Two Upcoming Investor Conferences OPK +5.56% GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)